Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue

Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue

Alzheimer’s disease (AD) is a neurodegenerative disorder defined by the progressive formation and spread of fibrillar aggregates of Aβ peptide and tau protein. Polymorphic forms of these aggregates may contribute to disease in varying ways since different neuropathologies appear to be associated wit...

Full description

Bibliographic Details
Main Authors:	Abdullah Al Bashit, Prakash Nepal, Theresa Connors, Derek H. Oakley, Bradley T. Hyman, Lin Yang, Lee Makowski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Neuroscience
Subjects:	Alzheimer’s disease x-ray scattering amyloid plaques neurofibrillary tangles Aβ
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2022.909542/full

Similar Items

Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease
by: Clara Muñoz-Castro, et al.
Published: (2022-02-01)

Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
by: Ellis Patrick, et al.
Published: (2017-07-01)

Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
by: Ali Azargoonjahromi, et al.
Published: (2024-03-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
by: Damiano Librizzi, et al.
Published: (2021-02-01)

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
by: Minghui Wang, et al.
Published: (2023-03-01)

How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
by: Luigi Donato, et al.
Published: (2023-07-01)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
by: Zhikun Shi, et al.
Published: (2022-11-01)

Selective In Vitro and Ex Vivo Staining of Brain Neurofibrillary Tangles and Amyloid Plaques by Novel Ethylene Ethynylene-Based Optical Sensors
by: Florencia A. Monge, et al.
Published: (2023-01-01)

Amyloid beta 1-42 and phoshorylated tau threonin 231 in brains of aged cynomolgus monkeys (Macaca fascicularis)
by: Huda Shalahudin Darusman, et al.
Published: (2014-11-01)

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis
by: Heather M. Terron, et al.
Published: (2024-04-01)

PICALM and Alzheimer’s Disease: An Update and Perspectives
by: Kunie Ando, et al.
Published: (2022-12-01)

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
by: Melissa E. Murray, et al.
Published: (2022-12-01)

Research Progress of Pyroptosis in Alzheimer’s Disease
by: Weiyue Xue, et al.
Published: (2022-06-01)

Modeling Traumatic Brain Injury in Human Cerebral Organoids
by: Santiago Ramirez, et al.
Published: (2021-10-01)

Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms
by: Sai Sreenivasamurthy, et al.
Published: (2023-03-01)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
by: Selma M. Soyal, et al.
Published: (2020-08-01)

Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s Disease
by: Geidy E. Serrano, et al.
Published: (2024-03-01)

Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)

From Small Peptides to Large Proteins against Alzheimer’sDisease
by: Pasquale Picone, et al.
Published: (2022-09-01)

Association between Sleep, Alzheimer’s, and Parkinson’s Disease
by: Sumire Matsumoto, et al.
Published: (2021-11-01)

Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
by: Chang-lan Chen, et al.
Published: (2022-06-01)

S100A6 and Its Brain Ligands in Neurodegenerative Disorders
by: Anna Filipek, et al.
Published: (2020-06-01)

Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
by: Christiana Bjorkli, et al.
Published: (2022-08-01)

Okadaic acid induces damage of human neuroblastoma cell line SH-SY5Y
by: LU Ya-lan, ZHOU Li, HAN Yun-lin, WANG Ke-wei, QIN Chuan
Published: (2022-06-01)

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
by: Tsuyoshi Nakai, et al.
Published: (2021-05-01)

Tau: The Center of a Signaling Nexus in Alzheimer’s Disease
by: Shahzad eKhan, et al.
Published: (2016-02-01)

Tear biomarkers for Alzheimer’s disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study
by: Nienke van de Sande, et al.
Published: (2023-08-01)

Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
by: Andrea González, et al.
Published: (2022-04-01)

Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
by: Adrian Florian Bălașa, et al.
Published: (2020-10-01)

Transfusion with Blood Plasma from Young Mice Affects rTg4510 Transgenic Tau Mice Modeling of Alzheimer’s Disease
by: Carlos M. Hernandez, et al.
Published: (2023-05-01)

Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer’s disease pathology: a population-based autopsy study in an admixed sample
by: Regina Silva Paradela, et al.
Published: (2023-12-01)

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
by: Evelin L. Schaeffer, et al.
Published: (2011-01-01)

Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles
by: Martin Nwadiugwu, et al.
Published: (2024-02-01)

Editorial: Apoptosis, autophagy, and mitophagy dysfunction in Alzheimer's disease: Evolving emergence and mechanisms
by: Rajkumar Singh Kalra, et al.
Published: (2022-10-01)

Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
by: Mafalda Soares Pádua, et al.
Published: (2024-02-01)

Anticholinesterase activity of Areca Catechu: In Vitro and in silico green synthesis approach in search for therapeutic agents against Alzheimer’s disease
by: Sushma Pradeep, et al.
Published: (2022-11-01)

Exploring the therapeutic efficacy of Chlorella pyrenoidosa peptides in ameliorating Alzheimer's disease
by: Shu-Mei Wang, et al.
Published: (2023-05-01)

Corpora amylacea negatively correlate with hippocampal tau pathology in Alzheimer’s disease
by: Julian D. Dallmeier, et al.
Published: (2024-02-01)